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Introduction
Proteinopathy, the toxic aggregation of misfolded or damaged pro-
teins, is involved in the pathogenesis of multiple diseases, including 
neurodegenerative disorders, skeletal myopathies, and heart fail-
ure (1–3). A common feature of these diseases is a deterioration of 
the protein quality control (PQC) system, a collection of pathways 
devoted to the repair or clearance of faulty proteins crucial for nor-
mal cell and organ function (4). In the heart, defective PQC path-
ways and toxic protein accumulation have been associated with 
hypertrophic and dilated cardiomyopathies, as well as idiopathic 
and ischemic heart disease (5–8). Central players of the PQC system 
are molecular chaperones and co-chaperones that mediate and sta-
bilize the correct conformation of nascent proteins, refold aberrant 
proteins to their functionally active native state, or target unfolded/
misfolded or aggregated substrates for degradation (9–11).
Mutations in the co-chaperone protein BCL-2–associated atha-
nogene 3 (BAG3) are associated with cardiac myopathies (12–17). A 
GWAS, involving multiple families with heart failure due to dilated 
cardiomyopathy (DCM), identified associated mutations in BAG3 
(17). In the same study, analysis of a large, 4-generation family iden-
tified a single amino acid substitution of glutamic acid 455 with 
lysine (E455K) in BAG3 as the unequivocal cause of DCM (17). The 
E455 residue lies within a highly evolutionarily conserved region 
within the BAG domain of BAG3 (17). BAG3 interacts with the nucle-
otide-binding domain (NBD) of the molecular chaperone HSP70/
HSC70 via its BAG domain, thereby modulating chaperone activity 
and regulating PQC (18). A recent study showed that mutation of this 
residue perturbed the interaction of BAG3 with HSC70 in vitro (19).
Decreased levels of BAG3 have also been described in a fam-
ily with idiopathic DCM and in unrelated patients with end-stage 
heart failure (14). BAG3 is a member of an evolutionarily con-
served family of molecular co-chaperones (20) that interact with 
chaperones of the HSP family, including HSP70, to modulate their 
function (18, 21–23). BAG3 is prominently expressed in cardiac 
and skeletal muscle tissues (24). However, little is known regard-
ing the specific requirements for BAG3 in cardiomyocytes or the 
mechanisms by which the BAG3 E455K missense mutation leads 
to the progression of cardiomyopathy.
Results
Loss of BAG3 in the heart leads to DCM, heart failure, and premature 
death. Decreased levels of BAG3 protein are found in failing human 
hearts (14). To ascertain whether failing mouse hearts, like their 
human counterparts, exhibit decreased BAG3, we performed Western 
blot analysis on cardiac tissue from 2 mouse models of cardiomyopa-
thy. Muscle LIM protein–KO (MLP-KO) mice are a model of DCM and 
show many signs seen clinically in heart failure (25). Mice submitted 
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ciency of BAG3 resulted in impaired postnatal growth, with Bag3–/– 
mice exhibiting decreased body weight (BW) and early lethality at 
3 to 4 weeks of age (Supplemental Figure 1, B–D), consistent with 
previous reports (24, 28).
Early lethality of BAG3-KO mice precluded the study of the 
role of BAG3 in adult heart function. To investigate the specific role 
of BAG3 in cardiomyocytes, we crossed Bag3-floxed (Bag3fl/fl) mice 
with cardiomyocyte-specific α-myosin heavy chain Cre-transgenic 
mice (αMHC-Cre mice) (29). This αMHC-Cre line was specifically 
shown to have normal cardiac function (30). Consistent with pub-
lished data, our echocardiography studies also showed that this 
to chronic transverse aortic constriction (TAC) develop cardiac hyper-
trophy, which progresses to dilation and heart failure, again model-
ing human disease (26). As with human failing hearts, we observed 
decreased BAG3 protein levels in both dilated MLP-KO mouse hearts 
and hypertrophic hearts isolated 4 weeks after TAC (Figure 1, A and 
B), supporting the idea of a crucial role of BAG3 in cardiac function.
To investigate the in vivo role of BAG3 in cardiac function, 
we generated BAG3-KO mice by crossing targeted mice contain-
ing Bag3-floxed alleles (Supplemental Figure 1A; supplemental 
material available online with this article; https://doi.org/10.1172/
JCI94310DS1) with global deleter Sox2-Cre mice (27). Global defi-
Figure 1. BAG3 deficiency leads to DCM and premature death. (A and B) Representative Western blot (A) and corresponding quantitative densitometric 
analysis (B) of BAG3 in WT and MLP-KO (MLP–/–) mouse hearts and hearts isolated from mice that had undergone TAC for 4 weeks. GAPDH served as a 
loading control. n = 4 mice per group. (C) Western blot analysis of BAG3 in different tissues from Bag3fl/fl αMHC-Cre–positive (CKO) and control (Ctrl) mice. 
GAPDH served as a loading control. n = 3 mice per group. SK, skeletal muscle. (D) Kaplan-Meier survival curves for CKO (n = 11) and control (n = 11) mice. (E) 
Representative microscopic views of whole mouse hearts (top, scale bars: 1 mm) and cross-sectional views of H&E-stained (middle, scale bars: 1 mm) and 
Masson’s trichrome–stained (bottom, scale bars: 50 μm) hearts isolated from control and CKO mice at 6 months of age. (F) Representative echocardio-
graphic images of control and CKO mice at 4 months of age. (G–I) Echocardiographic measurements for control and CKO mice (n = 10–11 mice at 2, 3, 4, and 
8 months of age) of (G) LV FS (% FS), (H) LVIDd, and (I) LVIDs. (J and K) HW to BW ratio (J) and HW to TL ratio (K) for control (n = 9) versus CKO (n = 8) mice 
at 4 months of age. (L–M) qRT-PCR analysis of cardiac fetal gene markers (L) and profibrotic genes (M) in control (n = 9) and CKO (n = 8) mouse hearts at 
4 months of age. Data were normalized to corresponding 18S levels, and CKO is expressed as the fold-change versus control. Data are represented as the 
mean ± SEM. *P < 0.05, by 2-tailed Student’s t test.
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of CKO mice at 4 months of age (Figure 1L), as were the profibrotic 
genes collagen α1 types I (Col1a1) and III (Col3a1) (Figure 1M). In 
addition, hemodynamic analyses showed that both the peak rate of 
pressure rise (dP/dtmax) and peak rate of pressure decline (dP/dtmin) 
were significantly reduced in CKO mice at as early as 10 weeks of 
age, indicating early impairment of cardiac contractile function in 
BAG3-deficient mice (Supplemental Figure 1, F and G). Consistent 
with hemodynamic studies, single myocyte contraction induced 
by field stimulation was also significantly reduced in BAG3-CKO 
cardiomyocytes when compared with control cardiomyocytes 
(Supplemental Figure 1, H and I), although the profiles of induced 
Ca2+ transients, including amplitude and tau, were not significant-
ly affected (Supplemental Figure 1, J and K). Taken together, these 
data demonstrated that loss of BAG3 impaired the cardiomyocyte 
contractile apparatus and that BAG3 was essential for maintaining 
normal cardiac structure and function.
BAG3 deficiency leads to the downregulation of protein levels of 
small HSPs and impaired autophagic flux. We next explored the 
molecular mechanisms by which BAG3 deficiency caused DCM. 
As a co-chaperone protein, BAG3 interacts with both ATP-depen-
dent high-molecular-weight HSPs and ATP-independent small 
HSPs (sHSPs) in large, functionally distinct multi-chaperone 
complexes (18, 32–34). BAG3 interacts with sHSPs through its 2 
IPV motifs (32, 33, 35). To determine the effects of Bag3 deletion 
on components of the chaperone complex, we evaluated protein 
samples from isolated adult cardiomyocytes of 2-month-old CKO 
mice and control mice. Western blot analysis revealed that the 
αMHC-Cre mouse line in the same genetic background (C57/B6) 
as that of our mouse models has normal cardiac function (Sup-
plemental Figure 2). Western blot analysis confirmed specific and 
effective deletion of Bag3 in Bag3fl/fl α-MHC-Cre–positive (BAG 
CKO) hearts compared with those of control Cre-negative Bag3fl/fl 
hearts (Figure 1C). Loss of BAG3 did not result in increased expres-
sion of other BAG family members (Supplemental Figure 1E). 
BAG3-CKO mice were viable at birth; however, they had a striking 
susceptibility to premature death (Figure 1D) consequent to DCM 
and heart failure (Figure 1, E–M). Only 9% of the BAG3-CKO mice 
survived past 20 months of age compared with 91% of the control 
littermates (Figure 1D). Morphological and histological analysis 
of BAG3-CKO hearts revealed marked cardiac enlargement with 
severe fibrosis in surviving 6-month-old CKO mice (Figure 1E). 
Echocardiography revealed an age-dependent decrease in left ven-
tricular (LV) systolic function (percentage of fractional shortening 
[FS]) in mice deficient for BAG3 (Figure 1, F and G). Consistent 
with histological observations, loss of BAG3 resulted in LV chamber 
dilation, as evidenced by a significant increase in end-diastolic LV 
internal diameter (LVIDd) and end-systolic LV internal diameter 
(LVIDs) (Figure 1, H and I). Heart weight to BW (HW/BW) and HW 
to tibia length (HW/TL) ratios were also significantly increased in 
CKO mice compared with controls at 4 months of age (Figure 1, J 
and K), with no observed difference in BW (data not shown).
Consistent with molecular evidence of cardiac remodeling (31), 
cardiac fetal gene markers, atrial natriuretic factor (Anf), and B-type 
natriuretic peptide (BNP) were significantly increased in the hearts 
Figure 2. BAG3 deficiency leads to the downregulation of protein levels of sHSPs. (A–D) Representative immunoblots (A and C) and quantification analysis 
(B and D) of BAG3, HSP90, HSP70, HSC70 (A and B), and HSPB5, -6, -7, and -8 (C and D) in adult cardiomyocytes isolated from control and CKO mice. n = 4 
mice per group. (E and F) Neonatal cardiomyocytes were isolated from Bag3fl/fl mice and infected with Ad-Cre (20 MOI) for 24, 48, and 72 hours. Ad-lacZ was 
used as a control. Representative immunoblots (E) and quantification analysis (F) of BAG3 and HSPB5, -6, and -8. n = 4. GAPDH served as a loading control. 
(G and H) Neonatal cardiomyocytes were isolated from Bag3 global-KO mice or WT controls and infected with BAG3-overexpressing adenovirus (Ad-BAG3) 
(20 MOI) for 36 hours. GFP adenovirus (Ad-GFP) was used as a control. Representative immunoblots (G) and quantification analysis (H) of HSPB5, -6, and -8. 
n = 4. GAPDH served as a loading control. Data are represented as the mean ± SEM. *P < 0.05, by 2-tailed Student’s t test or 2-way ANOVA.
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diminished 18 hours after CHX treatment and were undetectable 
24 hours after CHX treatment in BAG3-KO neonatal cardiomyo-
cytes. In contrast, in control WT neonatal cardiomyocytes, approx-
imately 50% of the overexpressed HSPB8 was still present 24 
hours after CHX treatment. Taken together, these data indicated 
that upon loss of BAG3, the levels of affected sHSPs were dimin-
ished as a result of protein instability.
As it has also been reported that BAG3 is involved in autoph-
agy (37), we next investigated how the loss of BAG3 might affect 
autophagic flux by examining the levels of the autophago some-
associated protein light chain 3B (LC3B) (38), which is present 
in cytosolic form (LC3B-I) until it becomes targeted to nascent 
autophagosomes (LC3B-II form) (39, 40). As expected, West-
ern blotting showed a significant decrease in LC3B-II levels in 
BAG3-CKO hearts compared with levels in control littermate 
hearts (Supplemental Figure 4, A and B). The selective autoph-
agy receptor p62 was also increased in BAG3-CKO hearts (Sup-
plemental Figure 4, C and D). Moreover, in cultured neonatal 
cardiomyocytes, starvation-induced autophagic LC3B-II levels 
were further decreased in BAG3-KO cells when compared with 
levels in WT cells (Supplemental Figure 4, E and F). To moni-
tor autophagic flux in vivo by fluorescence microscopy, we next 
crossed BAG3-CKO mice with GFP-LC3–transgenic mice (41). 
After 18 hours of starvation, we observed a reduction in LC3-GFP 
accumulation in BAG3-CKOLC3-GFP myocardium compared with 
controlLC3-GFP mouse myocardium, indicating that autophagic 
flux was suppressed in BAG3-deficient hearts (Supplemental 
Figure 4, G and H). Autophagic flux is a dynamic process that 
levels of stress-inducible HSPs, such as HSP90 and HSP70, were 
significantly upregulated in BAG3-CKO cardiomyocytes, where-
as levels of the constitutively expressed HSC70 were unchanged 
(Figure 2, A and B). These data suggested increased protein stress 
in cardiomyocytes deficient in BAG3. Interestingly, protein levels 
of sHSPs, such as HSPB8 (also known as HSP22), HSPB6 (also 
known as HSP20), and HSPB5 (also known as αB-crystallin) were 
significantly decreased in BAG3-CKO cardiomyocytes (Figure 2, C 
and D). It is noteworthy that the levels of HSPB7, a sHSP that does 
not interact with BAG3 (36), were not changed in CKO-mutant 
mouse hearts. To determine whether this reduction was a prima-
ry or secondary effect, we next isolated neonatal cardiomyocytes 
from Bag3fl/fl mice and deleted Bag3 using Cre adenovirus (Ad-Cre). 
Acute loss of BAG3 in cardiomyocytes led to the downregulation of 
sHSPs in a time-dependent manner (Figure 2, E and F). Further-
more, reexpression of BAG3 in BAG3-KO cells was able to rescue 
the expression of sHSPs (Figure 2, G and H). Next, we sought to 
determine why sHSP levels were diminished in the absence of 
BAG3. No changes in the mRNA levels of sHSPs were detected in 
WT or BAG3-KO hearts (Supplemental Figure 3A). We then per-
formed a cycloheximide (CHX) chase experiment to determine 
HSPB8 protein stability. Unfortunately, as shown in Supplemental 
Figure 3B, HSPB8 was undetectable, even at basal conditions with-
out CHX treatment in BAG3-KO cardiomyocytes. To overcome 
this problem, we then infected neonatal cardiomyocytes isolated 
from BAG3-KO and WT control mice with adenovirus to overex-
press tagged HSPB8 (Dendra2-HSPB8). As shown in Supplemental 
Figure 3C, the levels of overexpressed HSPB8 were significantly 
Figure 3. BAG3 deficiency leads to increased levels of a subset of insoluble proteins. (A) Silver staining of total and insoluble proteins in control and CKO 
mice. n = 4. (B) Western blot analysis of cypher L, ENH, α-actinin, myosin heavy chain (MyHC), desmin, vinculin, CAPZβ, and myozenin 1 in total and insol-
uble protein fractions of control and CKO mouse hearts. n = 4 mice per group. The blots shown were derived from replicate samples run on parallel gels. (C) 
Western blot analysis of the oxidative phosphorylation complexes in total and insoluble protein fractions from control and CKO mouse hearts. n = 4. (D) 
Scatter plot comparing the intensity of proteins from MS analysis of the insoluble fraction from CKO and control mouse hearts.
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BAG3 deficiency leads to increased levels of a subset of insolu-
ble proteins. Recent studies have found that, despite a paucity of 
age-dependent differences in the total cardiac proteome, signif-
icant age-dependent differences are observed among proteins 
isolated from detergent-insoluble protein aggregates (48, 49). 
Therefore, since we observed no significant changes in the total 
proteome of cardiac tissue from BAG3-deficient mice (Supple-
mental Figure 6), we next analyzed insoluble proteins by isolating 
detergent-insoluble protein fractions from BAG3-CKO and con-
trol hearts. Strikingly, upon equal loading of total protein lysates 
(Figure 3A, left), the sarcosyl-insoluble protein fraction from the 
aggregated protein components relative to those from control lit-
termate hearts (Figure 3A, right). To identify constituent proteins 
of the insoluble fraction, we used a candidate-based approach to 
evaluate the effects of BAG3 deficiency on the levels of a num-
ber of filament proteins critical for cardiac function (cypher L 
[LDB3], ENH, α-actinin, myosin heavy chain, desmin, vinculin, 
and CAPZβ). The results demonstrated a marked accumulation 
of these proteins in the insoluble protein fraction of BAG3-CKO 
hearts (Figure 3B). Conversely, these proteins were unchanged in 
total lysate samples (Figure 3B). We also detected an accumula-
tion of components of the mitochondrial oxidative phosphoryla-
tion (OXPHOS) pathway in both total and insoluble protein frac-
tions using an OXPHOS antibody cocktail (Figure 3C).
To profile the constituents of the insoluble protein fraction 
in BAG3-deficient hearts, we used label-free mass spectrometry 
(MS) to quantify protein profiles from control and BAG3-CKO 
mouse hearts. We identified approximately 700 proteins with-
in insoluble fractions of either WT or CKO samples. Scatter-plot 
analysis revealed that most of these proteins were more abundant 
in the insoluble protein fraction of BAG3-CKO hearts relative to 
that seen in controls (Figure 3D), with the levels of 101 proteins 
increased by more than 5-fold. We next validated the MS results 
by Western blot analysis and found that, in accordance with our 
proteomics data, a number of PQC pathway proteins (HSP70, 
HSP90, HSPB5, and p62), filament proteins (FLNC and tropomy-
starts with the formation of autophagosomes and ends with their 
degradation after fusion with lysosomes (42). Owing to the dif-
ficulty of monitoring this process in vivo, we analyzed BAG3-
CKO mouse neonatal cardiomyocytes cultured in the absence or 
presence of bafilomycin-A1, a v-ATPase inhibitor (43), or chloro-
quine, an inhibitor of autophagosome-lysosome fusion and auto-
phagosome degradation (39), to assess whether BAG3 regulates 
the formation and/or clearance of autophagosomes. Following 
bafilomycin-A1 and chloroquine treatment, LC3B-II remained 
at reduced levels in BAG3-CKO cardiomyocytes compared with 
levels in control cells (Supplemental Figure 4, I and J), indicating 
that BAG3 regulated autophagosome formation. Taken together, 
these results indicated that BAG3 deficiency results in the sup-
pression of autophagosome formation.
Impaired autophagy suggested that BAG3 deficiency might 
result in misfolded protein aggregates. In the chaperone network, 
sHSPs function as “holdases,” a term that refers to their ability 
to bind and stabilize denatured or non-native proteins against 
aggregation, subsequently bringing them to be refolded by HSP70 
(44, 45). Thus, dramatic downregulation of HSPB5, -6, and -8 
in BAG3 mutants would also be expected to lead to misfolded 
protein aggregates. To assess the presence of misfolded protein 
aggregates in BAG3 mutants, we first evaluated p62, a common 
component of cytoplasmic inclusions in protein aggregates (46), 
by immunofluorescence. Although p62 levels were increased in 
BAG3-CKO hearts (Supplemental Figure 5A), we did not detect 
aberrant aggregation of p62 or the aggregation-prone proteins 
desmin and αB-crystallin (CryAB) (Supplemental Figure 5, B and 
C). Moreover, electron-dense perinuclear protein aggregates, 
characteristic of aggresomes (7, 47), were not visible by transmis-
sion electron microscopic analysis of BAG3-CKO myocardium 
(data not shown). We also investigated whether the expression 
levels of some critical cardiac-specific proteins were changed with 
loss of BAG3 (Figure 3B). Quantitative proteomic analysis of total 
proteins from BAG3-CKO and control hearts revealed no signifi-
cant differences (Supplemental Figure 6).
Figure 4. Accumulation of BAG3-binding partners in the insoluble protein fraction from BAG3-CKO heart. (A) Silver staining of the TAP BAG3-interacting 
complex. MW, molecular weight. (B) Venn diagram showing overlapping proteins between the BAG3 TAP complex and increased insoluble proteins in CKO 
mouse hearts. (C) Western blot validation of proteins in the BAG3 interactome from total and insoluble protein fractions from control and CKO mouse 
hearts. The blots shown were derived from replicate samples run on parallel gels. n = 4 mice per group.
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osin), and mitochondrial proteins (FIS1, VDAC2, and MTCO2) 
were increased in the insoluble protein fraction of BAG3-CKO 
hearts. Myozenin and HADHB were unchanged, while UQCRB 
was decreased (Supplemental Figure 7A). Gene Ontology Enrich-
ment Analysis (GOEA) with Cytoscape modeling to provide a 
visual biomolecular interaction network (50) revealed that pro-
teins with increased levels in the insoluble fraction of BAG3-CKO 
hearts are involved in multiple essential pathways for maintain-
ing normal cardiac function, including muscle contraction, actin 
filament capping, cytoskeleton regulation, translation initiation, 
protein folding, ATP synthesis–coupled electron transport, the 
acetyl-CoA biosynthetic process, mitochondrial organization, 
response to ROS, cell junction assembly, and the proteasome 
core complex (Supplemental Figure 7B). These results indicated 
that BAG3 regulated several specific targets related to metabolic 
and contractile pathways. It should also be pointed out that BAG3 
could be detected in multiple cellular compartments, including 
mitochondrial and cytoplasmic fractions, and could also be found 
colocalizing with α-actinin at the Z-disc (Supplemental Figure 
8). Altogether, these findings suggested that perturbed PQC and 
insoluble protein accumulation of a subset of functionally import-
ant cardiomyocyte proteins were responsible for the development 
of heart failure in BAG3-CKO mice.
To further investigate specific substrates of the BAG3-chap-
erone complex in cardiomyocytes, we performed tandem affinity 
purification (TAP) in combination with MS analysis. We delivered 
an adenovirus expressing an N-terminal 3XFlag-HA tandem affin-
ity–tagged full-length BAG3 (3XFlag-HA-BAG3) as a bait protein 
into neonatal cardiomyocytes to affinity-purify endogenous pro-
teins that interacted with BAG3. Compared with the 3XFlag-HA-
Figure 5. The interaction between BAG3 and HSP70 is critical for sHSP stability. (A) Overlay of WT (blue) and E455K-mutant (orange) BAG3 domain 1H15N 
heteronuclear single-quantum correlation (HSQC) spectra. (B) ITC of the interaction of the HSP70 NBD with the WT (left) and E455K-mutant (right) BAG 
domain of BAG3. Upper panels represent the measure of enthalpy during titration. Lower panels represent the integrated binding isotherm of the titration 
and experimental fit to a single site model. (C) Representative Western blot analysis of HSC70, HSP70, and HSPB8 in input and the TAP BAG3-interacting 
complex. n = 3 (D and E) Representative Western blot (D) and corresponding quantitative analysis (E) of BAG3 and HSPB5, -6, and -8 in WT (+/+) and BAG3 
E455K-mutant (m/m) mouse hearts. GAPDH served as a loading control. n = 4 mice per group. Data are represented as the mean ± SEM. *P < 0.05, by 
2-tailed Student’s t test. (F) Western blot analysis of HSPB5, -6, and -8 and BAG3 in neonatal cardiomyocytes isolated from WT (+/+) and BAG3 E455K- 
mutant (m/m) hearts infected with WT Ad-BAG3 (20 MOI) for 36 hours. Ad-GFP was used as a control, and GAPDH served as a loading control. n = 4.
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GFP control affinity purification, multiple bands were present in the 
immune-precipitated BAG3-containing complex (Figure 4A). Using 
gel digestion MS, we identified the most intense band at 70 kDa 
as HSP70 and HSC70, which are known interactors of BAG3 (35). 
To comprehensively profile the BAG3 interactome, we performed 
on-bead digestion following TAP and subjected the immuno-
precipitated products to label-free proteomics (51). A total of 1,490 
proteins were affinity purified from cardiomyocytes expressing 
3XFlag-HA-BAG3 compared with 983 proteins pulled down from 
3XFlag-HA-GFP controls. To identify high-confidence BAG3 inter-
actors, proteins were filtered to have 2 or more matching queries and 
an enrichment of at least 20-fold over the GFP control group. This 
stringent cutoff yielded 123 potential binding partners. Interesting-
ly, several ATPase-independent sHSP family members (HSPB5, -6, 
and -8), and ATPase-dependent HSP70 family members (HSP70 
and HSC70), previously identified as part of the BAG3 complex 
(35), were among the 123 potential binding partners identified in 
this manner. Notably, of the 123 potential binding partners, 39 were 
overlapping with proteins identified as being increased within the 
insoluble protein fraction from BAG3-CKO hearts (Figure 4, B and 
C, Figure 3, B and E, and Supplemental Table 1). A 2-tailed Fisher’s 
exact test indicated that the overlap was highly significant (P < 2.2 
× 1016). These results indicated that BAG3 directly interacted with 
ATPase-independent and -dependent HSPs to ensure protein quali-
ty control of specific protein substrates, several of which also direct-
ly interact with the BAG3-chaperone complex.
Interaction between BAG3 and HSP70 is critical for sHSP sta-
bility. A human genetic linkage study involving a large, 4-genera-
tion family identified a single amino acid substitution of glutamic 
acid 455 with lysine (E455K) in BAG3 as the unequivocal cause 
Figure 6. Amino acid E455 is critical for BAG3 function. (A) Kaplan-Meier survival curves for BAG3 E455K-mutant homozygous (m/m), heterozygous 
(m/+), and WT control (+/+) mice. n = 10 mice per group. (B) Representative image illustrating the significant growth retardation in BAG3 E455K- mutant 
homozygous mice (m/m) compared with littermate control (+/+) mice at 20 days of age. Scale bar: 1 cm. (C) Growth curves of BAG3 E455K-mutant 
homozygous (m/m), heterozygous (m/+), and control (+/+) mice. n = 10 mice per group. (D) Representative microscopic views of whole mouse hearts and 
cross-sectional views of H&E-stained hearts isolated from cardiac-specific cMUT and control mice at 6 months of age. n = 3 mice per group. Scale bars: 
1 mm. (E and F) HW to BW ratio (E) and HW to TL ratio (F) for control (n = 7) versus cMUT (n = 6) mice at 5 months of age. (G and H) qRT-PCR analysis of 
cardiac fetal gene markers (G) and profibrotic genes (H) in control (n = 4) and cMUT (n = 4) mouse hearts at 5 months of age. Data were normalized to 
corresponding 18S levels, and cMUT is expressed as the fold-change versus control. (I) Silver staining of total and insoluble proteins in control and cMUT 
mice. n = 4. (J) Western blot analysis of proteins in the insoluble fraction of control and cMUT mouse hearts. n = 4 mice per group. Data are represented as 
the mean ± SEM. *P < 0.05, by 2-tailed Student’s t test.
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Notably, the BAG3 E455K mutation did not affect BAG3 binding 
to sHSPs (Figure 5C) (35). Taken together, we concluded that the 
ability of BAG3 to interact with HSP70 was essential to the stabili-
ty of sHSPs. These results suggested that the BAG3 E455K mutant 
would result in dysfunction of the chaperone complex, thus lead-
ing to cardiomyopathy.
The BAG3 E455K mutation impairs BAG3 function and leads 
to DCM. Indeed, homozygous global BAG3 E455K mutants 
exhibited impaired postnatal growth and premature lethality at 
4 weeks of age (Figure 6, A–C), reminiscent of BAG3 homozy-
gous global null mutants. Given that BAG3 protein levels were 
unchanged (Figure 5, D and E), our results suggested that the 
E455K mutation impaired the essential functions of BAG3. As 
early lethality of homozygous BAG3 E455K mutants preclud-
ed the study of BAG3 E455K mutation effects on adult heart 
function, we generated cardiac-specific BAG3 E455K-mutant 
(cMUT) mice using the αMHC-Cre–transgenic mouse line (29). 
Immunostaining analyses confirmed that there were no alter-
ations in BAG3 protein levels or in BAG3 localization in cMUT 
hearts compared with control hearts (Supplemental Figure 9D). 
As observed with CKO animals, the hearts of cMUT animals had 
increased levels of stress-inducible HSPs and impaired auto-
phagic flux (Supplemental Figure 9, E and F). In addition, cMUT 
mice had phenotypes comparable to those of BAG3-CKO mice, 
with marked cardiac enlargement, diminished systolic function, 
and activation of a fetal cardiac gene program (Figure 6, D–H, 
and Supplemental Figure 10).
As found in BAG3-CKO mice, the abundance of insoluble pro-
teins (Figure 6I) was dramatically increased in cMUT hearts. To 
determine whether the same proteins identified in the insoluble 
fraction of BAG3-CKO mouse hearts were also in the insoluble 
fraction of BAG3 cMUT mouse hearts, we performed Western 
of DCM (17). However, the pathogenic effects of this mutation 
are not known. BAG3 interacts with the NBD domain of HSP70/
HSC70 via its BAG domain. We first determined whether the 
mutation affects BAG domain folding by performing NMR spectra 
analyses. 1H15N HSQC spectra of both the WT and mutant BAG 
domain showed sharp, well-dispersed peaks characteristic of fold-
ed proteins, revealing that the mutation is compatible with folding 
(Figure 5A). We then determined the binding affinity between the 
BAG domain of BAG3 and the NBD (ATPase domain) of HSP70 
by isothermal titration calorimetry (ITC). Strikingly, the E455K 
mutation weakened the interaction by almost 50%, yielding com-
parable heat-release values of 8.8 and 8.9 kcal/mol, but differing 
KD affinities of 325 and 662 nM for WT and BAG3 E455K mutants, 
respectively (Figure 5B). Furthermore, TAP analysis using GFP 
control, WT BAG3, and E455K-mutant BAG3 proteins (BEK) over-
expressed in neonatal cardiomyocytes revealed that E455 was 
critical for the interaction between BAG3 and HSP70 (Figure 5C). 
Interestingly, the E455 mutation did not affect BAG3 binding to 
HSPB8 (Figure 5C).
To elucidate the biological and physiological consequences of 
the BAG3 E455K mutation, we generated BAG3 E455K– knockin 
(BEK-knockin) mice, in which the endogenous Bag3 gene was 
replaced with mutant BAG3 containing the E460K mutation 
(equivalent to the human E455K mutation; Supplemental Figure 9, 
A–C). Western blot analysis showed that BAG3 levels in the hearts 
of BAG3 homozygous E455K mice were comparable to BAG3 
protein levels in WT controls (Figure 5, D and E), suggesting that 
the E455K mutation does not impair the expression or stability of 
BAG3. Conversely, the protein levels of sHSPs (HSPB5, HSPB6, 
and HSPB8) were downregulated in E455K-mutant hearts (Fig-
ure 5, D and E), and overexpression of WT BAG3 protein rescued 
sHSP levels in BAG3 E455K-mutant cardiomyocytes (Figure 5F). 
Figure 7. Model for mechanisms 
underlying cardiomyopathy in BAG3 
mutants. WT BAG3 plays a critical 
role in the formation of multi-chap-
erone complexes and the stability of 
sHSPs, maintaining the PQC of BAG3 
complex substrates and normal heart 
function. Cardiomyocyte-specific 
KO of BAG3 (CKO) leads to dysfunc-
tion of the chaperone complex and 
destabilization of sHSPs, resulting 
in an increased insolubility of BAG3 
complex substrates and cardiomy-
opathy. The BAG3 E455K mutation 
leads to dysfunction of the chaperone 
complex and destabilization of sHSPs 
by disrupting the interaction between 
BAG3 and HSP70, resulting in an 
increased insolubility of BAG3 com-
plex substrates and cardiomyopathy. 
SBD, substrate-binding domain.
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studies with BAG3 demonstrated a significant overlap between 
proteins that were complexed with BAG3 and those that were 
increased in the insoluble fraction of mutants.
Altogether, our observations suggested that interaction 
between BAG3 and HSP70 is essential for the execution of BAG3 
function in stabilizing sHSPs and maintaining cardiomyocyte 
protein homeostasis (Figure 7). These findings indicate that the 
downregulation of BAG3 protein levels in the failing human heart 
(14) is likely to be of functional significance and to contribute to 
human heart failure, regardless of etiology. Our results suggest 
that increasing the protein levels of BAG3 may be of therapeutic 
benefit in heart failure.
Methods
Mouse models. C57BL/6 mice (strain code: 027) were purchased from 
Charles River Laboratories. FLPase (FLP) mice [B6.SJL-Tg(ACT-
FLPe)9205Dym/J, stock no. 005703] and Sox2-Cre mice [Tg(Sox2-
cre)1Amc/J, stock no. 004783] were purchased from The Jackson Lab-
oratory. Mice with Bag3 conditional alleles and lacZ and neo cassettes 
(B6N-Bag3tm1a, MGI: 1352493) (Supplemental Figure 1) were obtained 
from the International Knockout Mouse Consortium. Bag3-floxed 
(Bag3fl/fl) mice were generated by crossing B6N-Bag3tm1a mice with 
FLP deleter mice (59) to excise the lacZ and neo cassettes. BAG3 glob-
al-KO mice were subsequently generated by crossing B6N-Bag3tm1a 
mice with Sox2-Cre mice (27). To generate BAG3 cardiomyocyte–spe-
cific KO (CKO) mice, Bag3fl/fl mice were crossed with α-myosin heavy 
chain–transgenic (αMHC-Cre) mice (29). The corresponding littermate 
controls were Bag3fl/fl αMHC-Cre–negative mice. The GFP-LC3–trans-
genic mouse line (41) was from Noboru Mizushima’s laboratory at The 
University of Tokyo and was used to generate BAG3-CKOLC3-GFP mice.
BAG3 E455K (equivalent to the mouse E460K) knockin mice were 
generated by standard techniques using a targeting construct (60), in 
which codon 455 GAA (encoding glutamic acid) in exon 4 of Bag3 was 
changed to AAA (encoding lysine) and which contained a neomycin 
selection cassette flanked by FRT sites (59). Following electroporation 
of the targeting vector into R1 embryonic stem (ES) cells, G418-resis-
tant ES cells were screened for homologous recombination by Southern 
blot analysis as described below. One heterozygous recombinant ES 
clone was identified and microinjected into blastocysts from C57BL/6J 
mice to generate male chimeras. Male chimeras were bred with female 
C57BL/6J mice to generate germline-transmitted BAG3 E455K mice 
(Bag3m-neo/+). Bag3m-neo/+ mice were then crossed with FLP deleter mice 
to remove the neomycin gene. Bag3m/+ heterozygous mutant mice were 
backcrossed onto a C57BL/6 background for at least 10 generations. 
Bag3m/+ heterozygous mutant mice were subsequently intercrossed to 
generate homozygous Bag3m/m mice (BEK mice).
BAG3-CKO male mice (Bag3fl/fl αMHC-Cre–positive) were 
crossed with Bag3m/+ heterozygous mutant female mice to generate 
BAG3 cardiomyocyte–specific cMUT mice (Bag3fl/m αMHC-Cre–posi-
tive). BAG3 cMUT mice were bred with Bag3fl/fl mice to generate BAG3 
cMUT (Bag3fl/m αMHC-Cre–positive) and littermate control (Bag3fl/fl 
αMHC-Cre–negative) mice. Thus, the cMUT mice had a –/m genotype 
in cardiomyocytes and a fl/m genotype in all other cells of the body.
Animal procedures, echocardiography, and hemodynamics. Echocar-
diography was performed as previously described (60, 61). Briefly, mice 
were anesthetized with 1% isoflurane and underwent echocardiography 
using a FUJIFILM VisualSonics SonoSite Vevo 2100 ultrasound system 
blots analysis with antibodies against 14 proteins that had been 
found to be upregulated in the insoluble fraction of BAG3-CKO 
mouse hearts. As shown in Figure 6J, all 14 of the investigated 
proteins were upregulated in the insoluble fraction from cMUT 
hearts. Taken together, our results demonstrate that the BAG3 
E455K mutation is a loss-of-function mutation and imply that 
interaction with HSP70 is essential for normal BAG3 function in 
cardiomyocyte protein homeostasis and cardiac function.
Discussion
While it is clear that mutations in BAG3 result in human cardiac 
myopathies (12–17), little is known about the role of BAG3 in car-
diomyocytes or the adult heart, or about the mechanisms by which 
the BAG3 E455K missense mutation leads to the progression of 
cardiomyopathy. The present study demonstrated an essential 
role of BAG3 in cardiomyocytes for the maintenance of normal 
heart function, with loss of BAG3 leading to DCM. Specifically, 
BAG3 maintained normal heart function by exercising quality 
control over a specific subset of proteins required for the metabolic 
and contractile function of cardiomyocytes. We also found that 
cardiac-specific BAG3 E455K-mutant mice had DCM comparable 
to that of cardiomyocyte-specific BAG3-KO mice, demonstrating 
that E455K is a loss-of-function mutation and that this residue is 
critical for essential functions of BAG3.
The ATP-dependent HSP70 and the ATP-independent small 
sHSP/HSPB family, which includes HSPB8, HSPB6, and HSPB5, 
constitute an ancient system for protecting proteins under condi-
tions of proteotoxic stress (52). One major gap in the understand-
ing of the chaperone network is how sHSPs link to other network 
components. This question is important, because sHSPs them-
selves lack the ATPase activity that is required for active refold-
ing. The BAG domain of BAG3 binds HSP70 with high affinity 
(53), suggesting that BAG3 is a functionally important partner of 
HSP70. BAG3 also interacts with HSPB8 and other members of the 
sHSP/HSPB family through its 2 IPV motifs (32, 54), thus allowing 
BAG3 to assemble large multi-chaperone complexes. Our study 
demonstrated that the human BAG3 E455K mutation diminished 
the interaction of BAG3 with HSP70. Although the E455K muta-
tion did not affect the interaction of BAG3 with sHSPs, it markedly 
affected the stability of sHSPs (Figure 7).
We were not able to detect large aggregates in BAG3-CKO or 
cMUT mice by microscopic methods. Aggregates are operation-
ally defined by poor solubility in aqueous or detergent solvents, 
aberrant subcellular or extracellular localization, and a non-native 
secondary structure (55, 56). By using biochemical and proteomic 
methods, we found evidence for increased insoluble aggregates 
in BAG3-CKO and cMUT mice. Accumulating evidence suggests 
that proteotoxicity resulting from small aggregates of proteins 
can contribute to heart failure and hereditary heart diseases (57, 
58). Small protein aggregates may interfere with critical cellular 
functions by binding and obstructing key signaling or trafficking 
molecules, potentially leading to cell death (57, 58). In this regard, 
proteotoxicity resulting from small protein aggregates could be an 
important factor leading to the observed DCM phenotype in CKO 
and cMut animals. We found increased amounts of specific pro-
teins in the insoluble fraction from BAG3-CKO and cMUT mice 
compared with that detected in controls. Notably, our pulldown 
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NMR studies. WT and mutant BAG domains were produced in 
synthetic M9 medium with 15NH4Cl as a source of nitrogen. NMR 
spectra were recorded at the NMR facility of the UCSD Skaggs School 
of Pharmacy and Pharmaceutical Sciences. Two-dimensional 1H15N 
HSQC spectra on 0.25-mM samples were acquired at 22°C on a Bruker 
BMA600 equipped with cryogenic triple-resonance probes and pro-
cessed with TopSpin software (Bruker).
ITC. The NBD of murine HSP70 (UniProtKB/Swiss-Prot entry 
Q61696, residues 1–388) and the BAG domain of BAG3 (WT or 
E455K-mutant) (UniProtKB/Swiss-Prot entry Q9JLV1.2, residues 
419–509) were produced in E. coli. The constructs were cloned into 
PETM-11 vectors as N-terminal fusions with a His-tag and a TEV pro-
tease cleavage site and purified as described previously (68). The puri-
fied samples were dialyzed overnight into ITC buffer (25 mM HEPES, 
pH 7.5, 150 mM KCl, 5 mM MgCl2, 0.25 mM TCEP). ITC measure-
ments were done at the Protein Analysis Core of the Sanford Burnham 
Prebys Medical Discovery Institute using a MicroCal ITC200 System 
(Malvern). The measurements were collected by injecting BAG3 WT 
or E455K-mutant protein into the cell filled with HSP70-NBD solu-
tion. Control experiments were performed by titrating BAG3 WT or 
E455K-mutant protein into the cell filled with ITC buffer alone. The 
data were processed using MicroCal Origin Software (Malvern).
Additional details on the methods used in this study are provided 
in the Supplemental Methods.
Statistics. Data are presented as the mean ± SEM unless indicated 
otherwise. Statistical analysis was performed using GraphPad Prism 
6.0 (GraphPad Software), with a 2-tailed Student’s t test or 2-way 
ANOVA for comparisons among groups. Survival data were calculated 
using Kaplan-Meier survival analysis with a log-rank statistical meth-
od. P values of less than 0.05 were considered statistically significant.
Study approval. The UCSD animal care personnel maintained all 
animals, and the IACUC of UCSD approved all experimental proce-
dures. UCSD has an Animal Welfare Assurance document (A3033-
01) on file with the Office of Laboratory Animal Welfare and is fully 
accredited by the Association for Assessment and Accreditation of 
Laboratory Animal Care (AAALAC) International.
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